Geoffrey Ling MD

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Geoffrey Ling, MD
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Geoffrey Ling MD:

Company Role Class Num Shares Value Price $ Report Date Ownership
Celularity Inc Director Class A Common Stock 256,026 $284,188 $1.11 12 Jan 2026 Direct
CATALYST BIOSCIENCES, INC. Director Common Stock 31,790 $14,941 $0.4700 07 Jan 2022 Direct
Celularity Inc Director Stock Options 1,490,996 29 Dec 2025 Direct
CATALYST BIOSCIENCES, INC. Director Stock Option (Right to Buy) 14,000 09 Jun 2021 Direct

Insider Reports Filed by Geoffrey Ling MD

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CELU Celularity Inc 12 Jan 2026 1 $0 4/A Director 15 Jan 2026, 16:15
CELU Celularity Inc 29 Dec 2025 2 $0 4 Director 30 Dec 2025, 16:30
CELU Celularity Inc 19 Dec 2025 1 $0 4 Director 22 Dec 2025, 16:30
CELU Celularity Inc 19 Nov 2025 1 $0 4 Director 21 Nov 2025, 16:15
CELU Celularity Inc 19 Dec 2024 2 $0 4 Director 06 Jan 2025, 21:51
CELU Celularity Inc 31 Aug 2023 1 $0 4 Director 16 Oct 2023, 20:06
CELU Celularity Inc 31 Aug 2023 0 $0 3 Director 16 Oct 2023, 19:44
GYRE CATALYST BIOSCIENCES, INC. 07 Jan 2022 1 $0 4 Director 07 Jan 2022, 16:31
GYRE CATALYST BIOSCIENCES, INC. 01 Oct 2021 1 $0 4 Director 05 Oct 2021, 16:33
GYRE CATALYST BIOSCIENCES, INC. 09 Jun 2021 2 $0 4 Director 02 Jul 2021, 09:54